{"anticipatedPostingDate":"2009-11","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Patients who had transplant-related mortality (TRM). TRM = adverse event(s) that occur(s) after the patient has received a transplant, the principal investigator decides it is related to the procedure and the patient dies within 6 months.","groups":[{"description":"All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.","id":"OG000","title":"Evaluable Patients"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"6 Months Post Transplant","title":"Number of Participants (Patients) Who Died Due to Transplant.","type":"SECONDARY","unitOfMeasure":"Participants"}